129 related articles for article (PubMed ID: 2734590)
21. Intraduodenal conjugated bile salts exert negative feedback control on gall bladder emptying in the fasting state without affecting cholecystokinin release or antroduodenal motility.
van Ooteghem NA; Moschetta A; Rehfeld JF; Samsom M; van Erpecum KJ; van Berge-Henegouwen GP
Gut; 2002 May; 50(5):669-74. PubMed ID: 11950814
[TBL] [Abstract][Full Text] [Related]
22. Role of cholecystokinin in the control of gastric emptying and secretory response to a fatty meal in normal subjects and duodenal ulcer patients.
Konturek JW; Thor P; Maczka M; Stoll R; Domschke W; Konturek SJ
Scand J Gastroenterol; 1994 Jul; 29(7):583-90. PubMed ID: 7939393
[TBL] [Abstract][Full Text] [Related]
23. Effects of pancreatic polypeptide on biliary flow and bile acid secretion stimulated by secretin and cholecystokinin in the conscious pig.
Langlois A; Corring T; Levenez F; Cuber JC; Chayvialle JA
Regul Pept; 1990 Jan; 27(1):139-47. PubMed ID: 2309045
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man.
Regan PT; Go VL; DiMagno EP
J Lab Clin Med; 1980 Oct; 96(4):743-8. PubMed ID: 7419959
[TBL] [Abstract][Full Text] [Related]
25. Temporal relationships of cholecystokinin release, pancreatobiliary secretion, and gastric emptying of a mixed meal.
Fried M; Mayer EA; Jansen JB; Lamers CB; Taylor IL; Bloom SR; Meyer JH
Gastroenterology; 1988 Nov; 95(5):1344-50. PubMed ID: 3169498
[TBL] [Abstract][Full Text] [Related]
26. Plasma CCK levels in patients with pancreatic insufficiency.
Bozkurt T; Adler G; Koop I; Koop H; Türmer W; Arnold R
Dig Dis Sci; 1988 Mar; 33(3):276-81. PubMed ID: 3342719
[TBL] [Abstract][Full Text] [Related]
27. Bile inhibits release of cholecystokinin and neurotensin.
Gomez G; Lluis F; Guo YS; Greeley GH; Townsend CM; Thompson JC
Surgery; 1986 Aug; 100(2):363-8. PubMed ID: 3738760
[TBL] [Abstract][Full Text] [Related]
28. Feedback inhibition of cholecystokinin secretion by bile acids and pancreatic proteases.
Green GM
Ann N Y Acad Sci; 1994 Mar; 713():167-79. PubMed ID: 8185158
[TBL] [Abstract][Full Text] [Related]
29. Relationship between postprandial release of CCK and PP in health and in chronic pancreatitis.
Glasbrenner B; Dominguez-Muñoz JE; Nelson DK; Riepl RL; Büchler M; Malfertheiner P
Regul Pept; 1994 Feb; 50(1):45-52. PubMed ID: 8159806
[TBL] [Abstract][Full Text] [Related]
30. Gallbladder emptying and cholecystokinin and pancreatic polypeptide responses to a liquid meal in patients with diabetes mellitus.
Meguro T; Shimosegawa T; Satoh A; Suzuki H; Takasu A; Takayama A; Koizumi M; Toyota T
J Gastroenterol; 1997 Oct; 32(5):628-34. PubMed ID: 9349988
[TBL] [Abstract][Full Text] [Related]
31. The effect of the cholecystokinin receptor antagonist MK-329 on meal-stimulated pancreaticobiliary output in humans.
Cantor P; Mortensen PE; Myhre J; Gjorup I; Worning H; Stahl E; Survill TT
Gastroenterology; 1992 May; 102(5):1742-51. PubMed ID: 1568584
[TBL] [Abstract][Full Text] [Related]
32. Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. I. Bile duct obstruction with and without pancreatic duct obstruction.
Murayama KM; Samuel I; Toriumi Y; Solomon TE; Turkelson CM; Joehl RJ
J Surg Res; 1993 Feb; 54(2):126-31. PubMed ID: 7683071
[TBL] [Abstract][Full Text] [Related]
33. Increased circulating cholecystokinin in obstruction-induced acute pancreatitis. II. Pancreatic duct obstruction with and without bile duct obstruction.
Toriumi Y; Samuel I; Wilcockson DP; Turkelson CM; Solomon TE; Joehl RJ
J Surg Res; 1993 Feb; 54(2):132-5. PubMed ID: 8479170
[TBL] [Abstract][Full Text] [Related]
34. Regulation of pancreatic endocrine function by cholecystokinin: studies with MK-329, a nonpeptide cholecystokinin receptor antagonist.
Liddle RA; Gertz BJ; Kanayama S; Beccaria L; Gettys TW; Taylor IL; Rushakoff RJ; Williams VC; Coker LD
J Clin Endocrinol Metab; 1990 May; 70(5):1312-8. PubMed ID: 2186058
[TBL] [Abstract][Full Text] [Related]
35. Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man.
Hildebrand P; Beglinger C; Gyr K; Jansen JB; Rovati LC; Zuercher M; Lamers CB; Setnikar I; Stalder GA
J Clin Invest; 1990 Mar; 85(3):640-6. PubMed ID: 2312719
[TBL] [Abstract][Full Text] [Related]
36. Gallbladder dynamics in chronic pancreatitis. Relationship to exocrine pancreatic function, CCK, and PP release.
Glasbrenner B; Malfertheiner P; Pieramico O; Klatt S; Riepl R; Friess H; Ditschuneit H
Dig Dis Sci; 1993 Mar; 38(3):482-9. PubMed ID: 8444080
[TBL] [Abstract][Full Text] [Related]
37. Pathophysiological role of cholecystokinin in humans.
Otsuki M
J Gastroenterol Hepatol; 2000 Mar; 15 Suppl():D71-83. PubMed ID: 10759224
[TBL] [Abstract][Full Text] [Related]
38. Fasting and meal-induced CCK and PP secretion following intragastric balloon treatment for obesity.
Mathus-Vliegen EM; de Groot GH
Obes Surg; 2013 May; 23(5):622-33. PubMed ID: 23224567
[TBL] [Abstract][Full Text] [Related]
39. Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy.
Glasbrenner B; Dominguez-Munoz E; Riepl RL; Vetsi A; Malfertheiner P
Dig Dis Sci; 1995 Feb; 40(2):406-11. PubMed ID: 7851207
[TBL] [Abstract][Full Text] [Related]
40. Effects of ethanol on meal-stimulated secretion of pancreatic polypeptide and cholecystokinin: comparison of healthy volunteers, heavy drinkers, and patients with chronic pancreatitis.
Hirano H; Shimosegawa T; Meguro T; Shiga N; Koizumi M; Toyota T
J Gastroenterol; 1996 Feb; 31(1):86-93. PubMed ID: 8808434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
